This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.

We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.

Terms of use
Privacy Notice
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
This is a web analytics service.
Processing company
  • Google Ireland Limited
  • Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
  • Marketing
  • Advertisement
  • Web Analytics
Technologies Used
  • Cookies
  • Pixel Tags
Data Attributes
  • IP address (anonymised)
  • Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
  • Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • IP address
  • Date and time of visit
  • Usage data
  • Click path
  • App updates
  • Browser information
  • Device information
  • JavaScript support
  • Pages visited
  • Referrer URL
  • Downloads
  • Flash version
  • Location information
  • Purchase activity
  • Widget interactions
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 (1) (a) GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Alphabet Inc.
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
  • Facebook Ireland Limited
  • 4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
  • advertising
  • Marketing
  • Retargeting
  • Analyse
  • Tracking
Technologies Used
  • Cookies
Data Attributes
  • Pixel specific data
  • Http-Header
  • Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
  • Facebook user ID
  • Browser information
  • Usage data
  • Geräteinformationen
  • Non-sensitive custom data
  • Referrer URL
  • Pixel ID
  • Location information
  • Pixel specific data
  • User behaviour
  • Ads viewed
  • Interactions with advertisement, services, and products
  • Marketing information
  • Content viewed
  • IP address
Legal Basis
  • In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
  • Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
  • Republic of Serbia
Retention Period
  • The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
  • Facebook Inc.
10 million euros for the expansion of production
21. December 2022.
Hemofarm, the leader in the pharmaceutical market of Serbia and the surrounding region, one of the ten largest exporters in Serbia, expands its portfolio and begins the production of the world-famous brand Nizoral anti-dandruff shampoo through the investment of 10 million euros for the reconstruction and procurement of new production equipment.

STADA Group acquired the production portfolio Nizoral shampoos from Johnson&Johnson in 2019 and decided to transfer the production of these world-famous products to the production plant of Hemofarm in Šabac. The approved investment worth 10 million euros was used for reconstruction of the old blister packaging department, as well as for the procurement of the production equipment for as many as five new lines, which additionally expanded the production portfolio of liquid forms of this company.

The first reconstruction phase was completed in June 2022, when the production lines were put into operation, and during the tour of the production, Jesus Corchero Romero, Senior Vice President of STADA Group for Global Operations, emphasized the significance and value of this investment:

‘Our goal in Global Operations is to become the Preferred Supplier, on time…Every time, so we can support perpetual growth in all markets where we operate. Over the years, we have learned that for growing and performing better than others we must maximize our network capabilities and to invest in the best technologies in the right locations, showing at any time the flexibility to adapt to the demands of local markets and global business conditions. This investment will further strengthen the leadership position of STADA, not only in the local and regional markets where Hemofarm operates, but also in other markets around the world. After the complete reconstruction, our Sabac Site plant will be fully prepared to ensure the expected supply reliability with the new three fully automatic lines for the production of liquids, into bottles and pouches, and what is more important, it will create the opportunity for new jobs’, Mr. Romero said.





Validation of five different formulations of Nizoral shampoo 2 % has been done so far and production of optimization batch of Nizoral shampoo 1 % started in December.

‘The work on this project was extremely demanding. The plant that was reconstructed is located in the ‘heart’ of the factory, so it was necessary to ensure uninterrupted daily work, in addition to the reconstruction of over 1,000 m2 of space that is connected to the rest of the production. The dedication and experience of both production and management employees led to a successful implementation, and within six months (which is the period usually needed for only one line), as many as five new machines were successfully put into operation. After the complete reconstruction, the total production capacity will amount to 30 million packs of liquid forms’, Dejan Ivanović, Director of Operations of Hemofarm Group added.

Currently, 7 million packs of liquid forms are produced in HEMOFARM’s factory in Šabac, and when all the transfers related to this investment have been completed, the annual production will amount to 37 million packs of liquid forms, while reaching the full production capacity opens the space for more jobs.